Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Payables (2020 - 2025)

Beauty Health (SKIN) has disclosed Payables for 6 consecutive years, with $15.6 million as the latest value for Q4 2025.

  • Quarterly Payables fell 28.76% to $15.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $15.6 million through Dec 2025, down 28.76% year-over-year, with the annual reading at $15.6 million for FY2025, 28.76% down from the prior year.
  • Payables for Q4 2025 was $15.6 million at Beauty Health, down from $17.3 million in the prior quarter.
  • The five-year high for Payables was $44.8 million in Q4 2023, with the low at $15.6 million in Q4 2025.
  • Average Payables over 5 years is $27.5 million, with a median of $27.0 million recorded in 2022.
  • The sharpest move saw Payables skyrocketed 348994.41% in 2021, then crashed 50.99% in 2024.
  • Over 5 years, Payables stood at $29.0 million in 2021, then decreased by 2.0% to $28.5 million in 2022, then skyrocketed by 57.26% to $44.8 million in 2023, then plummeted by 50.99% to $21.9 million in 2024, then dropped by 28.76% to $15.6 million in 2025.
  • According to Business Quant data, Payables over the past three periods came in at $15.6 million, $17.3 million, and $23.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.